» Articles » PMID: 19684440

Molecular Mechanisms of Human Papillomavirus-induced Carcinogenesis

Overview
Specialties Genetics
Public Health
Date 2009 Aug 18
PMID 19684440
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 20% of all cancers are associated with infectious agents. Among them, human papillomaviruses (HPVs) are very common and are now recognized as the etiological agent of cervical cancer, the second most common cancer in women worldwide, and they are increasingly linked with other forms of dysplasia. Carcinogenesis is a complex and multistep process requiring the acquisition of several genetic and/or epigenetic alterations. HPV-induced neoplasia, however, is in part mediated by the intrinsic functions of the viral proteins. In order to replicate its genome, HPV modulates the cell cycle, while deploying mechanisms to escape the host immune response, cellular senescence and apoptosis. As such, HPV infection leads directly and indirectly to genomic instability, further favouring transforming genetic events and progression to malignancy. This review aims to summarize our current understanding of the molecular mechanisms exploited by HPV to induce neoplasia, with an emphasis on the role of the 2 viral oncoproteins E6 and E7. Greater understanding of the role of HPV proteins in these processes will ultimately aid in the development of antiviral therapies, as well as unravel general mechanisms of oncogenesis.

Citing Articles

Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.

Amiri S, Rasekh S, Moezzi S, Seifi N, Fatemi S, Fathi S Infect Agent Cancer. 2025; 20(1):16.

PMID: 40059217 PMC: 11892266. DOI: 10.1186/s13027-025-00643-5.


Are HPV oncogenic viruses involved in salivary glands tumorigenesis?.

Costin C, Chifu M, Pricope D, Grigoras A, Balan R, Amalinei C Rom J Morphol Embryol. 2024; 65(3):395-407.

PMID: 39529333 PMC: 11657354. DOI: 10.47162/RJME.65.3.02.


Human Papillomavirus and Associated Cancers: A Review.

Jensen J, Becker G, Jackson J, Rysavy M Viruses. 2024; 16(5).

PMID: 38793561 PMC: 11125882. DOI: 10.3390/v16050680.


Navigating therapeutic strategies: HPV classification in head and neck cancer.

Tabatabaeian H, Bai Y, Huang R, Chaurasia A, Darido C Br J Cancer. 2024; 131(2):220-230.

PMID: 38643337 PMC: 11263586. DOI: 10.1038/s41416-024-02655-1.


Molecular pathways in the development of HPV-induced oropharyngeal cancer.

Ullah M, Mikhailova M, Alkhathami A, Carbajal N, Zuta M, Rasulova I Cell Commun Signal. 2023; 21(1):351.

PMID: 38098017 PMC: 10722793. DOI: 10.1186/s12964-023-01365-0.


References
1.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

2.
Jones D, Thompson D, Munger K . Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 1998; 239(1):97-107. DOI: 10.1006/viro.1997.8851. View

3.
Kreimer A, Clifford G, Boyle P, Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):467-75. DOI: 10.1158/1055-9965.EPI-04-0551. View

4.
Patel D, Huang S, Baglia L, McCance D . The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 1999; 18(18):5061-72. PMC: 1171577. DOI: 10.1093/emboj/18.18.5061. View

5.
Pett M, Alazawi W, Roberts I, Dowen S, Smith D, Stanley M . Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 2004; 64(4):1359-68. DOI: 10.1158/0008-5472.can-03-3214. View